Enanta Pharmaceuticals Inc (ENTA) - News Archive

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a biotechnology company renowned for its innovation in small molecule drugs targeting viral infections and immunological diseases, has recently secured a significant mileston...

In a significant turn of events for the biotechnology industry, Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage firm focused on developing small molecule drugs for addressing virology and immunology condit...

Enanta Pharmaceuticals to Present Promising Phase 2 Results for RSV Treatment in Children WATERTOWN, Mass. Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company focused on developing small...

: Enanta Pharmaceuticals, Inc. recently reported its financial results for the fiscal year ending September 30, 2024. The clinical-stage biotechnology firm, known for its focus on developing small molecule drugs for vir...